Financhill
Back

Opus Genetics 10K Form

Sell
43

IRD
Opus Genetics

Last Price:
$1.16
Seasonality Move:
-10.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IRD News And Ratings

See the #1 stock for the next 7 days that we like better than IRD

IRD Financial Statistics

Sales & Book Value

Annual Sales: $11M
Cash Flow: $-9M
Price / Cash Flow: 0
Annual Sales: $0.11
Price / Book: 13.17

Profitability

EPS (TTM): -2.10000
Net Income (TTM): $-58.6M
Gross Margin: --
Return on Equity: -220.73%
Return on Assets: -131.97%

Opus Genetics Earnings Forecast

Key Opus Genetics Financial Ratios

  • The Research & Development expenses have been 244.28% of Revenue.
  • The Net Earning history of IRD is -523.40% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Opus Genetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IRD
Website: opusgtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.98
Quick Ratio: 1.92

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IRD Technical Analysis vs Fundamental Analysis

Sell
43
Opus Genetics (IRD) is a Sell

Is Opus Genetics a Buy or a Sell?

  • Opus Genetics stock is rated a Sell
    The current Opus Genetics [IRD] share price is $1.12. The Score for IRD is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.